A clinico-pathological study of subtypes in Parkinson's disease

Brain

Volumn 132, Issue 11, 2009, Pages 2947-2957

  Selikhova, M ^a,b   Williams, D R ^a,c,d   Kempster, P A ^a,c,e   Holton, J L ^a,c   Revesz, T ^a   Lees, A J ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

Author keywords

Age of onset; Bradykinesia; Lewy body; Parkinson's disease dementia; Tremor dominant phenotype

Indexed keywords

AMYLOID BETA PROTEIN;

ARTICLE; BRADYKINESIA; CLINICAL FEATURE; COGNITIVE DEFECT; DEATH; DEMENTIA; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; FALLING; HALLUCINATION; HUMAN; NEOCORTEX; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREMOR; VASCULAR AMYLOIDOSIS;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70350643450     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp234     Document Type: Article

References (45)

1. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197211.
2. Brooks DJ, Playford ED, Ibanez V, Sawle GV, Thompson PD, Findley LJ, et al. Isolated tremor and distribution of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 1992; 42: 155460.
3. Brooks DJ. Morphological and functional imaging studies on the diagnosis and progression of Parkinson disease. J Neurol 2000; 247 Suppl 2: 1118.
4. Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006; 77: 5859.
5. Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson's disease. Neurology 2008; 70: 101722.
6. Clarimó n J, Pagonabarraga J, Paisán-Ruíz C, Campolongo A, Pascual-Sedano B, Marti-Massó J, et al. Tremor dominant parkinsonism: clinical description and LRRK2 mutation screening. Mov Disord 2008; 23: 51823.
7. Colosimo C, Hughes AJ, Kilford L, Lees AL. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 8526.
8. Doder M, Rabiner EA, Turjanski N, Lees AJ, Brooks DJ. Tremor in Parkinson's disease and serotoninergic dysfunction: an 11C-WAY 100635 PET Study. Neurology 2003; 60: 6015.
9. Francis PT, Perry EK. Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Mov Disord 2007; 22 Suppl 17: S3517.
10. Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young-and old-onset Parkinson's disease. Neurology 1988a; 38: 14026.
11. Gibb WRG, Lees AJ. The relevance of the Lewy body to the patho-genesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988b; 51: 74552.
12. Graham JM, Sagar HJ. A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord 1999; 14: 1020.
13. Halliday G, Hely M, Reid W, Morris J. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008; 115: 40915.
14. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicentre study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 30: 83744.
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 42742.
16. Jellinger KA. Post mortem studies in Parkinson' disease-is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 1999; 56: 129.
17. Josephs KA, Matsumoto JY, Ahlskog E. Benign tremulous parkinsonism. Arch Neurol 2006; 63: 354357.
18. Kempster PA, Williams DR, Selikhova M, Holton J, Revesz T, Lees AJ. Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain 2007; 130: 21238.
19. Lashley T, Holton JL, Gray E, Kirkham K, O'Sullivan SS, Hilbig A, et al. Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients. Acta Neuropathol 2008; 115: 41725.
20. Lees AJ, Katzenschlager R, Head J, Ben-Shlomo Y. Ten-year follow-up of three different initial treatments in de-novo PD. Neurology 2001; 57: 168794.
21. Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J. Neurol Neurosurg Psychiatry 2005; 76: 34348.
22. Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression in Parkinson Disease. Arch Neurol 1999; 56: 3347.
23. Lyros E, Messinis L, Papathanasopoulos P. Does motor subtype influence neurocognitive performance in Parkinson's disease disease without dementia? Eur J Neurol 2008; 15: 2627.
24. McKeith I, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996; 47: 111324.
25. Marijama-Lyons J, Koller W. Tremor-predominant Parkinson's disease: approach to treatment. Drugs Aging 2000; 9: 2738.
26. O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2008; 23: 1016.
27. Paulus W, Jelliger K. The neuropathological basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991; 50: 74355.
28. Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 1996; 39: 3745.
29. Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, et al. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 2005; 26: 1183192.
30. Post B, Speelman JD. de Haan RJ; on behalf of the CARPA-study group.Clinical heterogeneity in newly diagnosed Parkinson's disease. J Neurol 2008; 255: 71622.
31. Quinn N, Critchley P, Marsden CD. Young onset Parkinson's disease. Mov Disord 1987; 2: 7391.
32. Quinn N. How to diagnose multiple system atrophy. Mov Disord 2005; 20 Suppl 12: S510.
33. Rajput AH, Pahwa R, Pahwa P, Rajput A. Prognostic significance of the onset mode in parkinsonism. Neurology 1993; 43: 82930.
34. Rajput AH, Robinson CA, Rajput AH. Benign tremulous Parkinsonism: a clinico-pathological study. Mov Disord 2008; 23: 31112.
35. Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, et al. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003; 62: 88598.
36. Schiess MC, Zheng H, Soukup VM, Bonnen JG, Nauta HJW. Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. Parkinsonism Relat Disord 2000; 6: 6976.
37. Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007; 22: 221015.
38. Schrag A, Ben-Shlomo Y, Marsden CD, Quinn N. Young-onset Parkinson's disease-clinical features, natural history, and mortality. Mov Disord 1998; 13: 88594.
39. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 2000; 123: 2297305.
40. Selikhova MV, Piatnitski? AN, Aristova RA, Belikova LP, Vialkova AB, Gusev EI. A differentiated approach to Parkinson's disease treatment in early stage of the disease. Zh Neurol Psikhiatr Im S S Korsakova 2004; 104: 249.
41. Spiegel J, Hellwig D, Samnick S, Jost W, Mö llers MO, Fassbender K, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease. J Neural Transm 2007; 114: 3315.
42. Tsuboi Y, Dickson DW. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? Parkinsonism Relat Disord. 2005; 11 Suppl 1: S4751.
43. Uchikado H, DelleDonne A, Ahmed Z, Dickson DW. Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 2006; 65: 38795.
44. Williams DR, Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128: 124758.
45. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985; 35: 522-6.